Testing effectiveness (Phase 2)UnknownNCT02481310
What this trial is testing
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
Who this might be right for
Adult Burkitt LymphomaB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt LymphomaDiffuse Large B-Cell Lymphoma+2 more
Northwestern University 38